315 related articles for article (PubMed ID: 7984146)
1. Divergent dimerization properties of mutant beta 1 thyroid hormone receptors are associated with different dominant negative activities.
Hao E; Menke JB; Smith AM; Jones C; Geffner ME; Hershman JM; Wuerth JP; Samuels HH; Ways DK; Usala SJ
Mol Endocrinol; 1994 Jul; 8(7):841-51. PubMed ID: 7984146
[TBL] [Abstract][Full Text] [Related]
2. Dominant and nondominant negative C-erbA beta 1 receptors associated with thyroid hormone resistance syndromes augment 12-O-tetradecanoyl-phorbol-13-acetate induction of the collagenase promoter and exhibit defective 3,5,3'-triiodothyronine-mediated repression.
Ways DK; Qin W; Cook P; Parker PJ; Menke JB; Hao E; Smith AM; Jones C; Hershman JM; Geffner ME
Mol Endocrinol; 1993 Sep; 7(9):1112-20. PubMed ID: 8247013
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
Piedrafita FJ; Ortiz MA; Pfahl M
Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome.
Collingwood TN; Adams M; Tone Y; Chatterjee VK
Mol Endocrinol; 1994 Sep; 8(9):1262-77. PubMed ID: 7838159
[TBL] [Abstract][Full Text] [Related]
5. A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor.
Usala SJ; Menke JB; Watson TL; Wondisford FE; Weintraub BD; Bérard J; Bradley WE; Ono S; Mueller OT; Bercu BB
Mol Endocrinol; 1991 Mar; 5(3):327-35. PubMed ID: 1653889
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of DNA binding affinity and dimerization properties of wild-type and mutant thyroid hormone receptor beta1.
Takeda T; Nagasawa T; Miyamoto T; Minemura K; Hashizume K; Degroot LJ
Thyroid; 2000 Jan; 10(1):11-8. PubMed ID: 10691308
[TBL] [Abstract][Full Text] [Related]
7. Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer.
Zhu XG; Yu CL; McPhie P; Wong R; Cheng SY
Endocrinology; 1996 Feb; 137(2):712-21. PubMed ID: 8593822
[TBL] [Abstract][Full Text] [Related]
8. Deoxyribonucleic acid binding and transcriptional silencing by a truncated c-erbA beta 1 thyroid hormone receptor identified in a severely retarded patient with resistance to thyroid hormone.
Behr M; Ramsden DB; Loos U
J Clin Endocrinol Metab; 1997 Apr; 82(4):1081-7. PubMed ID: 9100577
[TBL] [Abstract][Full Text] [Related]
9. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone.
Ng L; Forrest D; Haugen BR; Wood WM; Curran T
Mol Endocrinol; 1995 Sep; 9(9):1202-13. PubMed ID: 7491112
[TBL] [Abstract][Full Text] [Related]
10. An arginine to histidine mutation in codon 315 of the c-erbA beta thyroid hormone receptor in a kindred with generalized resistance to thyroid hormones results in a receptor with significant 3,5,3'-triiodothyronine binding activity.
Cugini CD; Leidy JW; Chertow BS; Bérard J; Bradley WE; Menke JB; Hao EH; Usala SJ
J Clin Endocrinol Metab; 1992 May; 74(5):1164-70. PubMed ID: 1314846
[TBL] [Abstract][Full Text] [Related]
11. Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation.
Nomura Y; Nagaya T; Tsukaguchi H; Takamatsu J; Seo H
Endocrinology; 1996 Oct; 137(10):4082-6. PubMed ID: 8828460
[TBL] [Abstract][Full Text] [Related]
12. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency.
Meier CA; Parkison C; Chen A; Ashizawa K; Meier-Heusler SC; Muchmore P; Cheng SY; Weintraub BD
J Clin Invest; 1993 Oct; 92(4):1986-93. PubMed ID: 8408652
[TBL] [Abstract][Full Text] [Related]
13. Competitive polymerase chain reaction quantitation of c-erbA beta 1, c-erbA alpha 1, and c-erbA alpha 2 messenger ribonucleic acid levels in normal, heterozygous, and homozygous fibroblasts of kindred S with thyroid hormone resistance.
Klann RC; Torres B; Menke JB; Holbrook CT; Bercu BB; Usala SJ
J Clin Endocrinol Metab; 1993 Oct; 77(4):969-75. PubMed ID: 8408473
[TBL] [Abstract][Full Text] [Related]
14. An arginine to histidine mutation in codon 311 of the C-erbA beta gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype.
Geffner ME; Su F; Ross NS; Hershman JM; Van Dop C; Menke JB; Hao E; Stanzak RK; Eaton T; Samuels HH
J Clin Invest; 1993 Feb; 91(2):538-46. PubMed ID: 8381821
[TBL] [Abstract][Full Text] [Related]
15. Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization.
Kitajima K; Nagaya T; Jameson JL
Thyroid; 1995 Oct; 5(5):343-53. PubMed ID: 8563470
[TBL] [Abstract][Full Text] [Related]
16. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA
Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935
[TBL] [Abstract][Full Text] [Related]
17. A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.
Usala SJ; Tennyson GE; Bale AE; Lash RW; Gesundheit N; Wondisford FE; Accili D; Hauser P; Weintraub BD
J Clin Invest; 1990 Jan; 85(1):93-100. PubMed ID: 2153155
[TBL] [Abstract][Full Text] [Related]
18. A new point mutation in the 3,5,3'-triiodothyronine-binding domain of the c-erbA beta thyroid hormone receptor is tightly linked to generalized thyroid hormone resistance.
Usala SJ; Menke JB; Watson TL; Bérard WE; Bradley C; Bale AE; Lash RW; Weintraub BD
J Clin Endocrinol Metab; 1991 Jan; 72(1):32-8. PubMed ID: 1846005
[TBL] [Abstract][Full Text] [Related]
19. A de novo mutation in an already mutant nucleotide of the thyroid hormone receptor beta gene perpetuates resistance to thyroid hormone.
Lado-Abeal J; Dumitrescu AM; Liao XH; Cohen RN; Pohlenz J; Weiss RE; Lebrethon MC; Verloes A; Refetoff S
J Clin Endocrinol Metab; 2005 Mar; 90(3):1760-7. PubMed ID: 15598685
[TBL] [Abstract][Full Text] [Related]
20. Generalized resistance to thyroid hormone: identification of a novel c-erbA beta thyroid hormone receptor variant (Leu450) in a Japanese family and analysis of its secondary structure by the Chou and Fasman method.
Hiramatsu R; Abe M; Morita M; Noguchi S; Suzuki T
Jpn J Hum Genet; 1994 Dec; 39(4):365-77. PubMed ID: 7873749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
